Relypsa Secures $75,900,000 New Financing Round

  • Feed Type
  • Date
    11/15/2013
  • Company Name
    Relypsa
  • Mailing Address
    700 Saginaw Drive Redwood City, CA 94063
  • Company Description
    Relypsa, Inc. (NASDAQ: RLYP) is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease.
  • Website
    http://www.relypsa.com
  • Transaction Type
    IPO
  • Transaction Amount
    $75,900,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.